TDH Update on Investigation of Adverse Events among Patients Receiving Methylprednisolone Acetate Injections
NASHVILLE – The Tennessee Department of Health will host a media briefing via telephone conference on reports of adverse events among patients in Illinois and North Carolina who received injections of methylprednisolone acetate produced by Main Street Family Pharmacy, LLC, in Newbern, Tenn. The briefing will take place on Friday, May 24 at 4 p.m. Central time. Media members may participate in the briefing via telephone by calling 1-888-757-2790, passcode 781337.
Participants in this conference call are asked to mute their phones after joining the call as a courtesy to other participants, and may unmute phones to ask questions. Participants should not put the call on hold at any time.
Who: John Dreyzehner, MD, MPH, Commissioner, Tennessee Department of Health
Tim Jones, MD, State Epidemiologist, Tennessee Department of Health
Marion Kainer, MD, MPH, Director, Healthcare Associated Infections & Antimicrobial Resistance Program, Tennessee Department of Health
Michelle J. Long, JD, Assistant Commissioner for Health Licensure and Regulation, Tennessee Department of Health
What: Update on investigation of adverse events associated with MPA injections
When: Friday, May 24, 4 p.m. Central time
Call-in information: Call 1-888-757-2790, Passcode: 781337
MEDIA CONTACTS: Woody McMillin, 615.741.3446 or Woody.McMillin@tn.gov OR Shelley Walker, 615.253.5184 or Shelley.Walker@tn.gov.